Histone Methyltransferase/Demethylase Activity Assay Service

CD BioSciences offers comprehensive histone methyltransferase (HMT) and demethylase (HDM) activity assay services to enable accurate profiling of enzymatic functions in epigenetic regulation. Our platform integrates advanced methodologies for quantifying methylation dynamics, supporting research in gene expression, disease mechanisms, and drug discovery. We provide end-to-end solutions tailored to diverse needs, from basic kinetic studies to high-throughput inhibitor screening.

Introduction to Histone Methyltransferase/Demethylase Activity Assay

Histone methylation is a central epigenetic mechanism that precisely regulates chromatin structure and function, thereby controlling gene expression and silencing. This balance is maintained by the coordinated actions of histone methyltransferases (HMTs and HDMs: HMTs transfer methyl groups from S-adenosylmethionine (SAM) to specific lysine (e.g., H3K4, H3K9, H3K27, H3K36) or arginine residues on histones, while HDMs remove these modifications, creating a dynamic epigenetic landscape. This "writing" and "erasing" dynamic is essential for normal cellular differentiation, developmental programming, and genomic stability.

Fig.1 Overall mechanism of methylation and demethylation on the R group nitrogen of the histone lysine tail. (Reed L, et al., 2024)

Functional assessment of HMT and HDM enzymatic activity is critical for understanding epigenetic regulation, validating the function of specific enzymes, and elucidating their roles in disease. For example, in cancer research, overexpression of HMTs (such as EZH2) or dysfunction of HDMs can disrupt methylation homeostasis, leading to aberrant activation of oncogenes or silencing of tumor suppressor genes. Activity assays, such as fluorescence probe-based supramolecular tandem assays and antibody-based detection methods—enable efficient and specific quantification of enzyme activity. This not only advances our understanding of their biological functions but also provides a core technological platform for high-throughput screening of targeted inhibitors and the development of novel epigenetic therapeutics.

Our Services

CD BioSciences develops customized activity assays to directly evaluate the catalytic function of histone methyltransferases and demethylases. Assays are tailored according to enzyme class, target residue, methylation state, and research objectives, enabling accurate assessment of enzymatic activity under defined conditions. Both recombinant enzymes and enriched endogenous preparations can be analyzed.

Assay Design and Substrate Option

To reflect different biological contexts, we offer multiple substrate formats:

1. Synthetic histone peptides with defined methylation sites
2. Recombinant histone proteins
3. Nucleosome-based substrates

Reaction parameters such as enzyme concentration, cofactors, incubation time, and buffer composition are optimized individually to ensure reliable signal detection.

Detection and Readout Methods

Enzymatic activity can be assessed using several validated readout strategies, including:

1. Modification-specific antibody detection
2. Fluorescence- or luminescence-based quantitative assays
3. Plate-based formats for dose–response studies
4. Gel-based confirmation assays

Orthogonal detection approaches may be employed to validate specificity.

Samples Requirements & Handling

Supported Sample Types

1. Purified Enzyme Samples: Recombinant proteins, commercial enzyme preparations, custom purified enzymes.
2. Biological Samples: Cell lysates, tissue samples, body fluids.
3. Substrate Samples: Histone proteins, histone peptides, nucleosomes, chromatin samples.
4. Compound Samples: Small molecule libraries, natural product extracts, clinical drug samples.

Sample Submission

1. Quality Requirements: Samples should meet specified purity standards (e.g., >90% for enzymes, >95% for substrates) and include documentation on concentration, buffer composition, and storage conditions.
2. Handling Guidelines: To preserve integrity, samples must be shipped on dry ice or with cold packs, accompanied by detailed sample information forms.

Special Sample Processing

1. Low-Abundance Samples: Utilization of enrichment techniques to enhance detection sensitivity.
2. Complex Matrix Samples: Optimization of extraction methods to minimize background interference.
3. Precious Clinical Samples: Development of micro-sample detection schemes to maximize data yield from limited materials.

Why Choose Us?

1. High Sensitivity and Specificity: Detect low-abundance activities with minimal interference using optimized detection systems.
2. Broad Dynamic Range: Accommodate diverse enzyme activities, from weak binders to highly active modifiers.
3. Custom Assay Development: Tailor assays for novel HMTs/HDMs, specific methylation sites, or unique research questions.
4. Integrated Data Analysis: Provide advanced bioinformatics support for kinetic modeling and pathway integration.

Frequently Asked Questions (FAQs)

CD BioSciences' HMT/HDM activity assay service delivers precise, actionable data to advance epigenetic research. Our combination of cutting-edge technologies, expert support, and rigorous quality control ensures reliable results for your projects. Contact us today for a free consultation to discuss your specific needs and receive a customized proposal.

Reference

1. Reed L, Abraham J, Patel S, et al. Epigenetic Modifiers: Exploring the Roles of Histone Methyltransferases and Demethylases in Cancer and Neurodegeneration[J]. Biology, 2024, 13(12): 1008.